Is Pharma being consolidated to one location?

[Anonymous]

Is pharma being consolidated to one location before the sale of the company?

 

[Anonymous]

Yes California and Rochester.

 

[Anonymous]

Yes California and Rochester.

My guess would be that Pharma would move out of Rochester. Rochester is the sight of Vision Care. It may be easier to separate Pharma from Vision Care so that a new company can buy just Vision Care or just Pharma rather than having to purchase both.

 

[Anonymous]

I am really confused when I look at the pharma organization of this company. Where is the nerve center for Pharma?

What is the purpose of having Pharma in New Jersey? Is New Jersey the nerve center? If it is not the Nerve center why does it even exist?

These kind of questions need to be answered before someone gives out 10 billion to buy this company.

 

[Anonymous]

I am really confused when I look at the pharma organization of this company. Where is the nerve center for Pharma?

What is the purpose of having Pharma in New Jersey? Is New Jersey the nerve center? If it is not the Nerve center why does it even exist?

These kind of questions need to be answered before someone gives out 10 billion to buy this company.

Obviously, four locations Tampa, New Jersey, Rochester and Cali for a relatively small Pharma organization is silly. Private equity firms are suppose to fix these problems before sale not pass them on to the next company.

 

[Anonymous]

The NJ office was opened to accommodate a few overpaid individuals that lived in the area. A lot of money was wasted relocating or rehiring to fill the office, mostly Schering Plough courtesy hires. There was and still is no need to have any Pharma in NJ.

 

[Anonymous]

The NJ office was opened to accommodate a few overpaid individuals that lived in the area. A lot of money was wasted relocating or rehiring to fill the office, mostly Schering Plough courtesy hires. There was and still is no need to have any Pharma in NJ.

How wasteful. If B+L is serious about selling this company they should announce the closing of the NJ facility in January. Gross inefficiencies do not go unnoticed during a negotiation.

 

[Anonymous]

Obviously, four locations Tampa, New Jersey, Rochester and Cali for a relatively small Pharma organization is silly. Private equity firms are suppose to fix these problems before sale not pass them on to the next company.

NJ= just offices no pharma
Tampa= extremely small pharma...more of troubleshoot manufacturing...i.e. no real R&D
Rochester = real R&D, all top researchers and projects located here
Cali= real R&D professionals here.

 

[Anonymous]

NJ= just offices no pharma
Tampa= extremely small pharma...more of troubleshoot manufacturing...i.e. no real R&D
Rochester = real R&D, all top researchers and projects located here
Cali= real R&D professionals here.

NJ=nerve center of Pharma

Rochester= We do not do research anymore why do we need them

Tampa= Warm weather, best in class manu

Cali= Why?

 

[Anonymous]

They will sell tampa and keep rochester and NJ most definately

 

[Anonymous]

Warburg and Schering retreads would most definitely like to move/close the Tampa manufacturing plant. Unlikely to happen.